Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Editor's choice for December 2015

Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015

Novel estrogen receptor-targeting agent represents ‘quantum leap’

Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA
Novel estrogen receptor-targeting agent represents ‘quantum leap’ ( Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA )
15 Dec 2015

ASH 2015: Latest in CLL

Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr Patrick Thornton
ASH 2015: Latest in CLL ( Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr Patrick Thornton )
7 Dec 2015

How can functional drug screening guide personalised cancer therapy?

Prof Jeff Tyner - Oregon Health & Science University, Portland, USA
How can functional drug screening guide personalised cancer therapy? ( Prof Jeff Tyner - Oregon Health & Science University, Portland, USA )
7 Dec 2015

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015

First targeted therapy for multiple myeloma effective against hard-to-treat disease

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark
First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )
6 Dec 2015

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA
First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival ( Dr Richard Stone - Dana Farber Cancer Institute, Boston, USA )
6 Dec 2015

Promising new strategy for treating children with acute lymphocytic leukaemia

Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA
Promising new strategy for treating children with acute lymphocytic leukaemia ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )
5 Dec 2015

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features

Dr Wendy Stock - University of Chicago, Chicago, USA
Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features ( Dr Wendy Stock - University of Chicago, Chicago, USA )
5 Dec 2015

Engineered cells to target multiple myeloma

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Engineered cells to target multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
5 Dec 2015

Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes

Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA
Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )
5 Dec 2015

Cancer Core Europe: where did it come from and what is its future?

Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark
Cancer Core Europe: where did it come from and what is its future? ( Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark )
4 Dec 2015